US Surgical Instruments Firm Plans Gulf Entry

Situation

AY Surgical is a US surgical instruments company planning its entry into the Gulf. I hold an advisory board seat with a single focus: Gulf entry.

Medtech is a harder entry than software. Three things have to line up at once. The product must be authorized for sale. The distributor must be qualified to store, handle and support it. The buyers are hospitals and health systems with their own procurement processes. Miss any one of the three and the other two do not matter.

The UAE regulatory picture is clear once you map it. In December 2024 the UAE issued a Federal Decree-Law on medical products, the pharmacy profession and pharmaceutical establishments. It covers medical devices among other products, and gives the Emirates Drug Establishment the job of issuing marketing authorizations for medical products (Gulf News). The UAE Government portal describes the Emirates Drug Establishment as responsible for managing and regulating medical products, including in free zones (u.ae). At emirate level, the Department of Health Abu Dhabi, the Dubai Health Authority and the Sharjah Health Authority regulate healthcare in their emirates (UAE Government portal).

What I did

An advisory board seat is only useful if it changes what the company does next. My contribution is a method I use on every regulated-product entry, and AY Surgical describes it in one line.

He maps the distributors, the regulators and the buyers before the first flight, then makes the calls himself." AY Surgical

Here is what each of those maps involves.

The regulator map. Which authority grants marketing authorization for the product category, which emirate-level health regulators matter for the target hospitals, and what documents the company already holds from its home market. I treat each GCC country as its own regulatory file, with its own sequence.
The distributor map. Who already supplies surgical instruments to the target hospitals, which of them hold the licences and storage to handle medical products, and which brands they carry that would compete with or complement a US line. A distributor with a competing flagship brand is rarely the right first partner.
The buyer map. Which hospital groups, government health systems and private specialty clinics buy this category, who signs, and how their procurement cycles run. This decides where the first demonstration happens.
The calls. Once the maps are drawn, I make the introductions myself, under Law II of my Laws of the Desk: engagement letter and NCNDA before the first introduction. Under Law III I am coordinator, never custodian, and I never hold client funds.

The order matters. Flying in before the maps exist produces polite meetings and no decisions.

Regulated products also need a time budget, not just a money budget. Authorization, distributor due diligence and hospital procurement each run on their own clock, and the slowest of the three sets the launch date. That is why all three maps start in the first month, side by side.

Result

Stage: Advisory role. I hold an advisory board seat with AY Surgical for its Gulf entry, and the entry is in its planning phase. I will publish signed outcomes when they are signed and agreed for publication, not before.

What a company gets at this stage is a plan that can survive contact with the market: a sequenced regulatory path, a distributor shortlist checked against real hospital relationships, and a buyer list with named decision-makers.

In medtech, the regulator decides if you can sell. The distributor decides if you will.

What you can take from this

If you run a US medical device or surgical instruments company, draw all three maps before you book a flight or a booth. Then use the table below as your first 30-day checklist.

The three maps for medical device market entry in the UAE

Map	What you need to know	Where to start	Output by day 30
Regulators	Who authorizes the product; which emirate health regulators matter for your target hospitals	Emirates Drug Establishment; DoH Abu Dhabi, DHA, Sharjah Health Authority; licensed regulatory counsel	A sequenced authorization path and document gap list
Distributors	Who already supplies your target hospitals, with what licences and brands	Introductions, chambers, US Commercial Service matchmaking	A shortlist of three to five vetted candidates
Buyers	Which hospitals and health systems buy your category, who signs, and when	Hospital groups, government health systems, specialty clinics	A named buyer list with a first demonstration target

Regulatory requirements change. Confirm every step with the relevant authority and licensed counsel. This is strategic advice, not legal or regulatory advice.

A 90-day Gulf entry plan for a US medtech company

Days 1–20: Build the regulator map and collect your home-market documentation. Choose the anchor emirate based on where your first buyers are.
Days 21–40: Build the distributor and buyer maps. Sign engagement terms with your advisor before any introductions go out.
Days 41–70: Meet the distributor shortlist and two or three anchor buyers in person. Test whether each distributor's hospital relationships are real.
Days 71–90: Agree distribution terms with one partner, file or schedule the authorization path, and set the first demonstration. Decide go or no-go by day 90.

How to do business in Dubai from the USA: routes, commercial agency basics and a 90-day plan.
US data-centre firm enters the GCC via Qatar: the same method, with a live distribution partnership.
How to find a distributor in the UAE: the vetting checklist.
Board and advisory roles: how I work on advisory boards.
All market entry case studies and the market entry hub.

Frequently asked questions

Who regulates medical devices in the UAE?

At federal level, the Emirates Drug Establishment manages and regulates medical products, including medical devices, and issues marketing authorizations under the Federal Decree-Law issued in December 2024. Emirate-level bodies such as the Department of Health Abu Dhabi, the Dubai Health Authority and the Sharjah Health Authority regulate healthcare in their emirates. Confirm current requirements with the authority and licensed counsel.

How does a US medical device company enter the UAE market?

Draw three maps first: the regulators who authorize your product, the distributors who already supply your target hospitals, and the buyers who sign. Then meet a distributor shortlist and anchor buyers in person, agree terms with one partner, and file the authorization path. I run this as a 90-day plan that ends in a go or no-go decision.

Do I need a local distributor to sell surgical instruments in the UAE?

Most foreign medtech companies start with a qualified local distributor, because the distributor holds the hospital relationships, storage and licences to handle medical products. The exact legal requirements depend on your product and structure, so confirm them with licensed UAE regulatory counsel. Choose the distributor for its real hospital relationships, not for its brochure.

What does an advisory board seat for Gulf entry involve?

For AY Surgical, my seat focuses on one job: Gulf entry. That means building the regulator, distributor and buyer maps, sequencing the market entry, and making the introductions myself once the maps are ready. A useful board seat changes what the company does next quarter. It is not a name on a slide.

Why not just exhibit at a regional healthcare trade show?

Trade shows work best after the maps are drawn. If you already know your regulatory path, your distributor shortlist and your target buyers, a show is an efficient week of meetings. Without that work, you collect business cards from distributors who already carry competing brands. Use the US Commercial Service matchmaking in Abu Dhabi and Dubai to make the week count.

How do I start working with you on a medtech entry?

Book a 15-minute fit call for USD 500. It is credited in full against any engagement within 30 days and refunded if I decline the file. If there is a fit, the usual next step is a 90-day advisory seat at USD 30,000 a month, which ends with a go or no-go decision.

Planning a Gulf entry for a regulated product?

Book a 15-minute fit call and I will tell you whether your regulator, distributor and buyer maps are ready. USD 500, credited in full within 30 days, refunded if I decline.

Book my 15-minute fit call Doing business in Dubai from the USA

Sources

Keep reading

Advisory

Medical Device Market Entry in the UAE: A US Surgical Instruments Firm Plans Gulf Entry